Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2021

Open Access 01.12.2021 | Research

The relationship between arterial stiffness index and coronary heart disease and its severity

verfasst von: Longjian Gao, Dasheng Lu, Guangwei Xia, Hao Zhang

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2021

Abstract

Background

Arterial stiffness index (ASI) is closely related to coronary atherosclerosis. This study aims to explore whether ASI can predict coronary heart disease (CHD) and its severity.

Methods

In this study, a total of 726 patients with suspected CHD were recruited. Based on coronary angiography results, the subjects were assigned into three groups: the control group (without obvious coronary artery disease), single-vessel disease group, and multi-vessel disease group (the number of vessels diseased ≥ 2). At the same time, according to the results of angiography, myocardial enzyme spectrum, electrocardiogram, color Doppler echocardiography and clinical manifestations, these patients were divided into four groups: the control group, stable angina (SA) Group, unstable angina (UA) group, and acute myocardial infarction (AMI) group. We have compared whether there were differences in ASI and related baseline data between groups. Receiver operating curve (ROC) analysis was conducted to determine whether ASI could predict CHD and evaluate the severity.

Results

ASI was positively correlated with the number of diseased branches of coronary artery. The value of ASI was increased as the number of the diseased branches increased. The ASI value in the SA group was significantly higher compared with the control group. Furthermore, the ASI value in the UA and AMI groups was remarkably increased compared with the control and SA groups. The results of ROC analysis indicated that the sensitivity and specificity of ASI was 71.0% and 85.4% in diagnosing CHD, respectively. While ASI was used in predicting the severity of CHD, the sensitivity was 72.1% and specificity 57.9%.

Conclusion

ASI is of great value in the diagnosis of coronary heart disease and the prediction of its severity.
Hinweise
Longjian Gao and Dasheng Lu have contributed equally to the work

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ASI
Arterial stiffness index
CHD
Coronary heart disease
SA
Stable angina
UA
Unstable angina
AMI
Acute myocardial infarction
ROC
Receiver operating curve
PWV
Pulse wave velocity
SBP
Systolic blood pressure
DBP
Diastolic blood pressure
AUC
Area under the curve
FBG
Fasting blood glucose
Lp(a)
Lipoprotein(a)
TC
Total cholesterol
TG
Triglyceride
LDL-C
Low-density lipoprotein-cholesterol
HDL-C
High-density lipoprotein-cholesterol
URIC
Uric acid

Background

Cardiovascular disease, especially CHD, is one of the important diseases affecting life and health. Although accumulating research has investigated the disease in the past, numerous related issues on diagnosis, treatment and prognosis remained to be resolved [1]. CHD is the synergy of multiple factors. In the past, the research mainly focused on the luminal lesions of coronary artery, especially lipid content, plaque stability and the biological characteristics of the fibrous cap. Recently, since arterial compliance is non-invasive and can be detected before the occurrence of cardiovascular disease, arterial elasticity changes have gained increasing attention.
Arteriosclerosis is an independent risk factor of CHD and other cardiovascular diseases [2, 3]. In recent years, it was believed that the occurrence and development of cardio-cerebrovascular diseases is resulted from the change of arterial wall elasticity (compliance), which predates the structural changes. Thus, research on arterial compliance at an early stage is of great necessity [4]. Arterial compliance mainly reflects arterial diastolic function, it mainly depends on the diameter, stiffness and expandability of blood vessels, which indicates vascular endothelial function to some extent [5, 6]. Therefore, the research on vascular compliance can provide a new target for the treatment of cardiovascular diseases [7]. ASI, an index of vascular elasticity measured by oscillography, can reflect the condition of the entire cardiovascular system. Common indicators of vascular elasticity include pulse pressure, pulse wave velocity (PWV), etc. Studies have shown that ASI was closely related with PWV. Reduced cardiovascular compliance is related with remarkably increased ASI, especially in patients with vascular sclerosis [8].
Based on previous studies, detecting ASI could predict CHD and evaluate its severity. This can provide new reference for the diagnosis and treatment of CHD in the future.

Methods

Patients and the groups

We selected 933 patients with suspected CHD who were hospitalized in the Department of Cardiology, Affiliated Hospital of Yangzhou University from January 2019 to December 2020, finally, 726 patients were selected. Among these patients, patients with AMI mainly come from emergency department, and other patients mainly come from cardiology outpatient department. The exclusion criteria are as follows: 1. Severe liver, kidney and pancreatic diseases; 2. Chronic wasting diseases and malignant tumors; 3. Frequent ectopic arrhythmias; 4. Those who do not cooperate with the inspection. All the subjects underwent coronary angiography based on the requirements of the American Heart College (ACC)/American Heart Association (AHA) coronary angiography guidelines. We mainly observed the lesions of left anterior descending (LAD) branch, left circumflex (LCX) branch, right coronary artery (RCA) and their main branches [9], as shown in Fig. 1a. The severity of coronary artery disease was evaluated according to the results of the examination [10]. According to the number of diseased branches of coronary artery (degree of stenosis ≥ 50%), all the subjects were assigned into three groups, including the control group (no vascular with stenosis degree ≥ 50%), and the single-vessel disease group (one vessel with stenosis degree ≥ 50%), multi-vessel disease group (two or more blood vessels with stenosis degree ≥ 50%). In addition, according to the results of color Doppler echocardiography, electrocardiogram, myocardial enzyme spectrum, and patient's clinical manifestations, the subjects were assigned into four groups, including the control group (coronary heart disease was excluded), the SA group, the UA group, and the AMI group. All the subjects signed the informed consent form for clinical research. This research was approved by the Ethics Committee of Yangzhou University.

Cardiovascular risk factors

Related risk factors such as gender, weight, age, smoking history, diabetes history, hypertension history, etc. were obtained from all the subjects through questionnaire surveys according to protocols [9].

Blood biochemical test

Venous blood samples were obtained in the early morning after admission. By using the fully automatic biochemical analyser (OLYMPUS AU2700, JAPAN), related blood biochemical indicators were detected, including cholesterol (TC, mmol/L), triglycerides (TG, mmol/L), high-density lipoprotein cholesterol (HDL-C, mmol/L), low-density cholesterol lipoprotein (LDL-C, mmol/L), lipoprotein(a)[LP(a), mmol/L], uric acid (UA, mmol/L), etc. All tests were performed at the Clinical Laboratory Center of the Affiliated Hospital of Yangzhou University. The laboratory quality control standards were met in this test.

Measurement of ASI

Basic principles Our study was to record the pressure shock wave when blood pressure was measured by oscillometry with an arterial meter. In the process of blood pressure measurement, the inflation pressure in the cuff gradually decreased after reaching the predetermined maximum value, and the arterial blood flow pressure wave detected in the cuff showed regular changes. When the cuff pressure was higher than the systolic pressure, the brachial artery blood flow was completely blocked. The brachial artery above the cuff expanded due to cardiac contraction, so the cuff pressure showed small fluctuations. When the cuff pressure was lower than the systolic pressure, with the gradual opening of the brachial artery below the cuff, the blood flow increased gradually, and the cuff pressure fluctuation amplitude recorded also increased gradually. When the cuff pressure was equal to the average pressure, the pressure fluctuation in the cuff reached the maximum. After that, the cuff pressure decreased gradually, and the pressure fluctuation decreased accordingly. When the cuff pressure was equal to the diastolic pressure, the pressure fluctuation amplitude decreased significantly. After that, as the blood flow was completely unblocked, and the pressure fluctuation amplitude in the cuff tensed to be stable. The ASI value was defined as the width value of the pressure fluctuation diagram corresponding to 80% of the peak height of the maximum pressure wave multiplied by 10, We also designed the basic schematic diagram, as shown in Fig. 1b.
Measurement method The subject was required to rest at least 15 min before the measurement. During the measurement, the subject took a seated position with the cuff placed on about 5 cm above the elbow joint of the right upper limb. The maximum inflation pressure of the air cuff (maximum pressure was 300 mmHg) was dependent on the blood pressure of the subjects. When the internal pressure of the cuff reached the maximum inflation pressure, inflation was automatically stopped. Then the cuff automatically deflated at a constant rate. After deflation, ASI, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure and heart rate could be automatically displayed. During the measurement, the subject kept normal breathing with the whole body relaxed, and avoided moving arms. The measurement was repeated for 3 times to obtain the average value. The time interval between adjacent measurements was more than 5 min. Japanese CardioVision MS-2000 arterial stiffness measuring instrument was used in this experiment.

Receiver operating curve (ROC) analysis and its significance

Medcalc software was used to draw the ROC. The area under the curve (AUC) was compared and the cut-off value of ASI evaluated, which were used to determine the occurrence and severity of CHD. The severity of CHD was mainly judged by comparing single-vessel lesions with multiple-vessel lesions.

Statistical analysis

In this study, SPSS 22.0 (Chicago, IL, USA) statistical software package was used for data analysis. For the data conforming to the normal distribution, mean ± standard deviation was used. One-way analysis of variance or independent sample t test was applied to compare the differences between groups. The chi-square test was used in analyzing the proportional data. For the data not conforming to the normal distribution, the median and interquartile range was used. Univariate and multivariate regression analysis was used to evaluate the relationship between the severity of CHD and ASI value. The P value was two-sided, and P ≤ 0.05 was considered statistically significant.

Results

A total of 726 patients participated in the study. All patients underwent coronary angiography. According to the results of the examinations, 562 participants were diagnosed with CHD (at least one vessel with vasculopathy degree ≥ 50%), while the other 164 patients were regarded as control group (no one vessel with vasculopathy degree ≥ 50%). Among patients with CHD, there were 340 patients in the single-vessel disease group and 222 patients in the multi-vessel disease group. According to the severity of clinical manifestations, among patients with CHD, there were 164 patients suffered from stable angina, 236 patients unstable angina and 162 patients with acute myocardial infarction.

The relationship between ASI degree and severity of coronary artery stenosis

As shown in Table 1, according to the number of diseased branches of coronary artery, all the participants were assigned into three groups. Compared with the control group, the participants were elder in single-vessel stenosis group and the multi-vessel stenosis group. In addition, hypertension, FBG, and ASI levels were significantly elevated in the single-vessel stenosis group, and there was no significant difference in other aspects. In the multi-vessel stenosis group, the levels of LDL-C, Lp(a), URIC, FBG, ASI were significantly increased, and there was no significant difference in other aspects. Compared with the single-vessel stenosis group, age, hypertension severity, Lp(a), LDL-C, URIC, and ASI were remarkably increased in the multiple-vessel disease group. After adjusting for baseline data such as male, age, BMI, smoking, hypertension, diabetes, HDL-C, LDL-C, TC, TG, Lp(a), URIC, and FBG, there was still an independent correlation between ASI level and the severity of coronary artery disease, with an odd ratio (OR) of 1.031 (multi-vessel stenosis group vs control group, 95% confidence interval (CI) 1.023–1.040, P < 0.05).
Table 1
The relationship between ASI degree and severity of coronary artery stenosis
Group
Control
Single
Multiple
P
N
164
340
222
 
Male (%)
125 (76)
259 (76)
166 (75)
0.919
Age (years)
59.94 ± 11.03
63.46 ± 10.38#
66.18 ± 9.92#*
 < 0.001
BMI (Kg/m2)
25.16 ± 3.04
24.99 ± 3.95
24.95 ± 3.28
0.832
Smoking (%)
72(44)
141 (41)
93 (42)
0.871
Hypertension (%)
78(48)
219(64)#
169(76)#*
 < 0.001
Diabetes (%)
19(12)
50(15)
44(20)
0.073
HDL-C (mmol/L)
1.08 ± 0.29
1.04 ± 0.23
1.02 ± 0.53
0.365
LDL-C (mmol/L)
2.14 ± 0.62
2.18 ± 0.74
2.33 ± 0.76#*
0.022
TC (mmol/L)
3.78 ± 0.81
3.76 ± 0.96
3.90 ± 0.96
0.186
TG (mmol/L)
2.14 ± 0.62
2.18 ± 0.74
2.33 ± 0.76
0.057
Lp(a)(mmol/L)†
159(113–248)
193(104.25–277.75)
231(133–326)#*
0.002
URIC(mmol/L)
364.09 ± 90.89
368.01 ± 85.68
389.62 ± 86.94#*
0.005
FBG (mmol/L)†
5.08(4.37–5.93)
5.75(4.93–6.34)#
5.71(5.18–6.52)#
 < 0.001
ASI†
48 (38–57)
80.5(51–131)#
134.5(79–210)#*
 < 0.001
indicated median and inter-quartile range, HDL-C = high density lipoprotein-cholesterol, LDL-C = low density lipoprotein-cholesterol, TC = total cholesterol, TG = triglyceride, Lp(a) = lipoprotein(a), URIC = uric acid, FBG = fasting blood glucose, ASI = Arterial stiffness index. #P < 0.05 versus control group, *P < 0.05 versus single group

The relationship between ASI level and severity of clinical manifestations

According to the severity of clinical manifestations, all the participants were assigned into four groups (Table 2). Compared with the control group, FBG and ASI levels were significantly elevated in the SA group. In the UA group, age, hypertension, URIC, FBG, and ASI etc. were remarkably increased. Age, hypertension levels, TG, FBG, ASI, etc. were dramatically higher in the AMI group. Compared with the SA group, age, h hypertension, URIC, ASI in the UA group were significantly increased. Age, hypertension, TG, and ASI were remarkably elevated in the AMI group. Compared with the UA group, BMI, TG, etc. were significantly increased in the AMI group, but there was no significant difference in ASI. After adjusting for baseline data such as male, age, BMI, smoking, hypertension, diabetes, HDL-C, LDL-C, TC, TG, Lp(a), URIC, and FBG, there was still an independent correlation between ASI level and the severity of clinical manifestations, with odd ratio (OR) of 1.029 (AMI group vs control group, 95% confidence interval (CI) 1.020–1.038, P < 0.05).
Table 2
The relationship between ASI level and severity of clinical manifestations
Group
Control
SA
UA
AMI
P
N
164
164
236
162
 
Male (%)
125(76)
122(74)
175(74)
128(79)
0.695
Age (years)
59.94 ± 11.03
60.45 ± 10.47
66.55 ± 10.15#*
65.73 ± 9.07#*
 < 0.001
BMI (Kg/m2)
25.16 ± 3.04
24.92 ± 3.76
25.41 ± 4.00
24.40 ± 3.07&
0.045
Smoking (%)
72(44)
72(44)
86(36)
76(47)
0.167
Hypertension (%)
78(48)
93(57)
175(74)#*
120(74)#*
 < 0.001
Diabetes (%)
19(12)
23(14)
40(17)
31(19)
0.242
HDL-C (mmol/L)
1.08 ± 0.29
1.07 ± 0.25
1.00 ± 0.22
1.05 ± 0.60
0.148
LDL-C (mmol/L)
2.14 ± 0.62
2.32 ± 0.81
2.16 ± 0.73
2.27 ± 0.72
0.057
TC (mmol/L)
3.78 ± 0.81
3.92 ± 0.93
3.71 ± 0.97
3.86 ± 0.96
0.133
TG (mmol/L)
1.51 ± 0.70
1.62 ± 0.77
1.64 ± 0.79
1.81 ± 0.87#*&
0.007
Lp(a) (mmol/L)
159(113–248)
199(105.5–327.5)
193(105–291.5)
235(140.25–316.5)
0.088
URIC (mmol/L)
364.09 ± 90.89
366.81 ± 94.69
387.18 ± 80.63#*
370.90 ± 85.80
0.033
FBG (mmol/L)
5.08(4.37–5.93)
5.79(4.96–6.39)#
5.83(5.01–6.39)#
5.49(5.11–6.22)#
 < 0.001
ASI
48(38–57)
57(43–79)#
133(90–170.50)#*
120(67–170.75) #*
 < 0.001
indicated median and inter-quartile range, #P < 0.05 versus control group, *P < 0.05 versus SA group, &P < 0.05 versus UA group

Using ASI cut-off value in the diagnosing CHD and evaluating its severity

ROC analysis was used to determine the role of ASI in diagnosing CHD and assessing its severity (Fig. 2). The areas under the curve (AUC) in Fig. 2a and b was 0.795 and 0.668, respectively. The sensitivity and specificity of ASI were 71.0% and 85.4% in diagnosing CHD. The sensitivity and specificity of ASI were 72.1% and 57.9% in predicting the severity of CHD.

Discussion

Coronary arteriosclerosis is one of the important causes of CHD [11], and blood vessel elasticity is closely related to coronary arteriosclerosis. Previous studies have demonstrated that ASI could indicate the compliance of the systemic vascular system, especially large blood vessels [8, 12, 13]. Thus, it was believed that by detecting ASI, the occurrence and severity of ischemic cardiovascular disease, especially coronary heart disease could be evaluated. Our study confirmed that the ASI level was significantly higher in the patients with CHD than that of the normal people. The ASI level in the patients with multi-vessel stenosis was remarkably higher compared with single-vessel stenosis. With the aggravation of clinical manifestations, the ASI of patients in the UA group and AMI group was significantly increased compared with the normal and SA group. To a certain extent, these findings confirmed that ASI was closely related to CHD and its severity. The reason why ASI could have such an effect is a question worthy of further investigation.
As is known to all, vascular endothelial cells can synthesize and release a variety of vasoactive substances, which play a vital role in maintaining vascular functions, such as vasodilation, inhibition of platelet adhesion, and the proliferation of vascular smooth muscle cell [14, 15]. Previous studies have presented that some risk factors, such as age, blood sugar imbalance, hypertension, blood lipid level imbalance, etc. could cause vascular endothelial damage, which in turn contributed to an imbalance of vasoactive factors secreted by endothelial cells. These could result in the structural changes of the vascular wall, and ultimately decreased vascular compliance [16]. Our research showed that there were significant differences in basic data such as age, hypertension, and blood sugar levels in the patients with CHD compared with normal people. There was also obvious difference in blood lipid levels in some subgroups. With the increase in the number of vessels diseased and the aggravation of clinical manifestations, the difference was also increased. These factors with significant difference were risk factors for vascular endothelial damage. Arterial endothelial injury leads to changes in arterial wall structure and diastolic and systolic function, which is the main reason for the decrease in arterial elasticity [17]. Therefore, our results further confirmed this view.
Reduced vascular compliance resulted from endothelial dysfunction generally occurs earlier than atherosclerotic plaque formation, which is the earliest manifestation of vasculopathy [18, 19]. The essence of CHD is the result of coronary artery disease [20]. Higher ASI level indicated that the arterial elasticity is worse. Presented by logistic regression analysis, ASI was not only related with the number of vessels diseased, but also with the clinical classification of CHD. Loss of arterial elasticity is an independent risk factor for CHD, this is consistent with the results in the research by Nigam et al. [21]. It was believed that endothelial function damage is the key link between them. In summary, with the increase of age and influence of some vascular-related risk factors, vascular endothelium is injured, resulting in decreased vascular compliance, this further contributes to vascular sclerosis, and thereby promoting the occurrence and development of CHD.
Our study was the first research using ROC analysis to determine the diagnostic value of ASI for CHD. The results of ROC analysis showed that ASI could not only serve a part in the predictive diagnosis of CHD, but also played a pivotal role in assessing the severity of CHD. Higher ASI value indicated that CHD was more serious. There are also some limitations in our research. First of all, our research time was relatively short and the number of cases was relatively small. Secondly, we have not performed vascular endothelial cell function test, which may require further validation in future animal experiments. Finally, for some patients with microvascular disease (without actual clinical significance), their test results might have some impact on our research, however, we believed that these impacts were limited.

Conclusions

In short, as one of the indicators reflecting vascular compliance, ASI closely related to the severity of CHD. Our research results demonstrated that ASI could provide a new basis for predicting and diagnosing CHD, which also could provides a new idea for the prevention and treatment of CHD in the future.

Acknowledgements

To our PCI team and other medical workers who participated in the study.

Declarations

All the study was approved by the institutional review board of Ethical Committee of Yangzhou University. All the recruited patients provided written informed consent. The administrative permissions from Yangzhou University were acquired by our team to access the data we used in our research. The study was conducted in accordance with 1964 Helsinki Declaration.
Signed consents were obtained from the enrolled patients to use their clinical information and sequencing data for publications.

Competing interests

All authors declare no conflicts of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Zhang H, Gao Y, Wu D, Zhang D. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease. BMC Cardiovasc Disord. 2020;20(1):295.CrossRef Zhang H, Gao Y, Wu D, Zhang D. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease. BMC Cardiovasc Disord. 2020;20(1):295.CrossRef
2.
Zurück zum Zitat Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res Off J Jpn Soc Hypertens. 2002;25(3):359–64.CrossRef Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res Off J Jpn Soc Hypertens. 2002;25(3):359–64.CrossRef
3.
Zurück zum Zitat Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002;105(7):886–92.CrossRef Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002;105(7):886–92.CrossRef
4.
Zurück zum Zitat Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res Off J Jpn Soc Hypertens. 2002;25(3):351–8.CrossRef Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res Off J Jpn Soc Hypertens. 2002;25(3):351–8.CrossRef
5.
Zurück zum Zitat Duprez DA, Jacobs DR Jr, Lutsey PL, Bluemke DA, Brumback LC, Polak JF, Peralta CA, Greenland P, Kronmal RA. Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2011;174(5):528–36.CrossRef Duprez DA, Jacobs DR Jr, Lutsey PL, Bluemke DA, Brumback LC, Polak JF, Peralta CA, Greenland P, Kronmal RA. Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2011;174(5):528–36.CrossRef
6.
Zurück zum Zitat Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol. 2007;20(Suppl 12):S45-50.PubMed Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol. 2007;20(Suppl 12):S45-50.PubMed
7.
Zurück zum Zitat Duprez DA. Is vascular stiffness a target for therapy? Cardiovasc Drugs Therapy Spons Int Soc Cardiovasc Pharmacother. 2010;24(4):305–10.CrossRef Duprez DA. Is vascular stiffness a target for therapy? Cardiovasc Drugs Therapy Spons Int Soc Cardiovasc Pharmacother. 2010;24(4):305–10.CrossRef
8.
Zurück zum Zitat Park SM, Seo HS, Lim HE, Shin SH, Park CG, Oh DJ, Ro YM. Assessment of arterial stiffness index as a clinical parameter for atherosclerotic coronary artery disease. Circ J. 2005;69(10):1218–22.CrossRef Park SM, Seo HS, Lim HE, Shin SH, Park CG, Oh DJ, Ro YM. Assessment of arterial stiffness index as a clinical parameter for atherosclerotic coronary artery disease. Circ J. 2005;69(10):1218–22.CrossRef
9.
Zurück zum Zitat Cai A, Li G, Chen J, Li X, Li L, Zhou Y. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. BMC Cardiovasc Disord. 2015;15:14.CrossRef Cai A, Li G, Chen J, Li X, Li L, Zhou Y. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. BMC Cardiovasc Disord. 2015;15:14.CrossRef
10.
Zurück zum Zitat Silber S. ESC guidelines 2019 on chronic coronary syndrome (CCS, previously “stable coronary artery disease”): what is new? What is particularly important? Herz. 2019;44(8):676–83.CrossRef Silber S. ESC guidelines 2019 on chronic coronary syndrome (CCS, previously “stable coronary artery disease”): what is new? What is particularly important? Herz. 2019;44(8):676–83.CrossRef
11.
Zurück zum Zitat Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens. 2001;14(8 Pt 2):258S-263S.CrossRef Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens. 2001;14(8 Pt 2):258S-263S.CrossRef
12.
Zurück zum Zitat Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P. Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol. 2019;30(6):918–28.CrossRef Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P. Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol. 2019;30(6):918–28.CrossRef
13.
Zurück zum Zitat Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arteriosc Thromb Vasc Biol. 2005;25(5):932–43.CrossRef Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arteriosc Thromb Vasc Biol. 2005;25(5):932–43.CrossRef
14.
Zurück zum Zitat De Meyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997;39(4):325–42.CrossRef De Meyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997;39(4):325–42.CrossRef
15.
Zurück zum Zitat Gardner AW, Parker DE. Predictors of large and small artery elasticity in healthy subjects from 9 to 89 years old. Am J Hypertens. 2011;24(5):599–605.CrossRef Gardner AW, Parker DE. Predictors of large and small artery elasticity in healthy subjects from 9 to 89 years old. Am J Hypertens. 2011;24(5):599–605.CrossRef
16.
Zurück zum Zitat Cohn JN. Arteries, myocardium, blood pressure and cardiovascular risk: towards a revised definition of hypertension. J Hypertens. 1998;16(12 Pt 2):2117–24.PubMed Cohn JN. Arteries, myocardium, blood pressure and cardiovascular risk: towards a revised definition of hypertension. J Hypertens. 1998;16(12 Pt 2):2117–24.PubMed
17.
Zurück zum Zitat Bellien J, Favre J, Iacob M, Gao J, Thuillez C, Richard V, Joannides R. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension. 2010;55(3):674–80.CrossRef Bellien J, Favre J, Iacob M, Gao J, Thuillez C, Richard V, Joannides R. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension. 2010;55(3):674–80.CrossRef
18.
Zurück zum Zitat Brumback LC, Jacobs DR Jr, Dermond N, Chen H, Duprez DA. Reproducibility of arterial elasticity parameters derived from radial artery diastolic pulse contour analysis: the multi-ethnic study of atherosclerosis. Blood Press Monit. 2010;15(6):312–5.CrossRef Brumback LC, Jacobs DR Jr, Dermond N, Chen H, Duprez DA. Reproducibility of arterial elasticity parameters derived from radial artery diastolic pulse contour analysis: the multi-ethnic study of atherosclerosis. Blood Press Monit. 2010;15(6):312–5.CrossRef
19.
Zurück zum Zitat Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, Glogar D. Arterial compliance: a diagnostic marker for atherosclerotic plaque burden? Am J Hypertens. 2003;16(5 Pt 1):356–62.CrossRef Syeda B, Gottsauner-Wolf M, Denk S, Pichler P, Khorsand A, Glogar D. Arterial compliance: a diagnostic marker for atherosclerotic plaque burden? Am J Hypertens. 2003;16(5 Pt 1):356–62.CrossRef
20.
Zurück zum Zitat Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N, Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement—a survey of 12517 subjects. Atherosclerosis. 2003;166(2):303–9.CrossRef Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N, Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement—a survey of 12517 subjects. Atherosclerosis. 2003;166(2):303–9.CrossRef
21.
Zurück zum Zitat Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92(4):395–9.CrossRef Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92(4):395–9.CrossRef
Metadaten
Titel
The relationship between arterial stiffness index and coronary heart disease and its severity
verfasst von
Longjian Gao
Dasheng Lu
Guangwei Xia
Hao Zhang
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2021
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02350-6

Weitere Artikel der Ausgabe 1/2021

BMC Cardiovascular Disorders 1/2021 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.